Printer Friendly

Idiopathic Pulmonary Fibrosis Treatment Market Global Size Expected to Register a Growth of CAGR of 12.3% Till 2025 - Latest Professional and Clinical Assessment Report 2019.

M2 PRESSWIRE-August 12, 2019-: Idiopathic Pulmonary Fibrosis Treatment Market Global Size Expected to Register a Growth of CAGR of 12.3% Till 2025 - Latest Professional and Clinical Assessment Report 2019

(C)1994-2019 M2 COMMUNICATIONS

RDATE:12082019

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Research by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

The Global Idiopathic Pulmonary Fibrosis Treatment Market is expected to register a CAGR of 12.3% during the forecast period of 2019 to 2025, with a market value of USD 2,237 million in 2018. Idiopathic Pulmonary Fibrosis Treatment Market Overview

Idiopathic Pulmonary Fibrosis Treatment is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market.

The global IPF treatment market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position.

We Offer you to Get a FREE Sample at https://www.marketresearchfuture.com/sample_request/6791

"Idiopathic Pulmonary Fibrosis (IPF) Treatment Market" Research report provide valuable insight with following companies, which includes -

*Boehringer Ingelheim GMBH *Biogen *Novartis AG *Medicinova Inc. *Bristol-Myers Squibb Company *Galapagos NV *Hoffmann-La Roche AG *Fibrogen Inc. *Cipla *Merck & Co. Inc. *Prometic Life Sciences Inc. *and others.

The "Idiopathic Pulmonary Fibrosis Treatment Market" highlights the information about the industries and market, technologies, and abilities over the trends and the developments of the industries. Readers are provided with a detailed outlook of the global Idiopathic Pulmonary Fibrosis Treatment Market, which includes carefully calculated revenue and volume growth, CAGR, and market share estimations.

For instance, FibroGen, Inc. announced that the grant of Fast Track designation by US Food and Drug Administration (FDA) for the company's anti-CTGF antibody, Pamrevlumab, for the treatment of patients with IPF. Segmentation

The global IPF treatment market has been segmented based on treatment.

*Drug Class

*MAPK Inhibitors *Tyrosine Kinase Inhibitors *Autotaxin Inhibitors *Others

*Oxygen Therapy *Lung Transplant *Others

Access complete Premium Research Report along with TOC, List of Figures and Tables at https://www.marketresearchfuture.com/reports/stereotactic-surgery-devices-market-6791 Global Idiopathic Pulmonary Fibrosis Treatment Market, by Region:

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The IPF treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European IPF treatment market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe.

The IPF treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The IPF treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

The report presents an all-inclusive database in a systematic and highly comprehensive manner. It intends to offer valid, factual, reliable, and easily understandable information about the Idiopathic Pulmonary Fibrosis Treatment Market which makes it more eloquent. Our analysis team applies a tried and tested primary and secondary research methodology to provide accurate and indubitable findings.

About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Media Contact

Company Name: Market Research Future

Contact Person: Abhishek Sawant

Email: sales@marketresearchfuture.com

Phone: +1 646 845 9312

Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar

City: Pune

State: Maharashtra

Country: India

Website: https://www.marketresearchfuture.com/reports/idiopathic-pulmonary-fibrosis-treatment-market-8109

Source: www.abnewswire.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to info@m2.com)).
COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Presswire
Article Type:Report
Geographic Code:90ASI
Date:Aug 12, 2019
Words:750
Previous Article:Industrial Tape Market 2019 Top Manufacturers, Global Analysis, Segments, Business Strategies, Industry Size, Share, Future Scope and Recent Trends...
Next Article:Automotive Thermal Management System Market 2019 Size, Share, Growth, Trends, Competitive Landscape, Emerging Technologies, Regional Analysis With...
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters